Dr. Páris Sidiropoulos
Angestellt, Principal Global Medical Science Director - Duchenne Muscular Dystrophy, Fa. Hoffmann - La Roche
Basel, Schweiz
Werdegang
Berufserfahrung von Páris Sidiropoulos
Bis heute 1 Jahr und 4 Monate, seit Feb. 2023
Principal Global Medical Science Director - Duchenne Muscular Dystrophy
Fa. Hoffmann - La Roche
2 Jahre und 1 Monat, Jan. 2021 - Jan. 2023
Principal Global Medical Science Director - Neuroimmunology
Fa. Hoffmann - La Roche
1 Jahr und 3 Monate, Okt. 2019 - Dez. 2020
Principal Medical Science Director - Neuroscience
Genentech
1 Jahr und 1 Monat, Sep. 2018 - Sep. 2019
Senior Medical Science Director - Immunology
Genentech Inc.
7 Monate, Feb. 2018 - Aug. 2018
Medical Science Director - Immunology
Genentech Inc.
2 Jahre und 1 Monat, Jan. 2016 - Jan. 2018
Global Scientific Communications Director - Immunology
F. Hoffman-La Roche Ltd.
2 Jahre und 11 Monate, Nov. 2012 - Sep. 2015
Medical Manager Rheumatology
Roche Pharma (Schweiz) AG
• Clinical trial operations – assistance and budgeting of clinical trials • Drug regulatory affairs – support approval of new product indications • KOL collaborations – discuss and initiate scientific and medical projects • Financial management – responsible for medical budget and HCP-sponsorships
• Establishment of in vivo and in vitro models to study peripheral neuropathies • Supervision of Master students and teaching assistant for practical courses • Collaborations with national and international research laboratories
10 Monate, Okt. 2005 - Juli 2006
Diplomand
The Scripps Research Institute, La Jolla
• Development of ELISA to screen organic compound libraries • Fluorescence labeling of antibodies targeting cellular prion protein • Recombinant expression and purification of cellular prion protein (FPLC)
3 Monate, Feb. 2005 - Apr. 2005
Neurovirologie
Deutsches Primatenzentrum
Multicolor flow cytometry for monitoring immunological parameters in SIV-infected macaques
Interference of the Cytomegalovirus on CD-1 molecules
Production of inducible retroviral expression vectors to study the Src kinase
Synthesis of Jasplakinolide, a potential anti-cancer drug
Ausbildung von Páris Sidiropoulos
4 Jahre und 7 Monate, Dez. 2006 - Juni 2011
Neurowissenschaften
Eidgenössische Technische Hochschule (ETH) Zürich
• “Cellular functions and dysfunctions of Dynamin-2 in the peripheral nervous system” • Supervised by Prof. Dr. Ueli Suter, Institute of Cell Biology • Certificate „International Ph.D. Program in Neuroscience” of the Life Science Zurich Graduate School
2005 - 2006
Immunologie
The Scripps Research Institute
• Development of ELISA to screen organic compound libraries • Fluorescence labeling of antibodies targeting cellular prion protein • Recombinant expression and purification of cellular prion protein (FPLC)
2000 - 2006
Biochemie
Freie Universität Berlin
• Major subject: Biochemistry • Minor subjects: Immunology and Biophysics • Final grade: A
Sprachen
Deutsch
-
Englisch
-
Französisch
-
Griechisch
-